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Abstract  
OBJECTIVE: Neauvia Stimulate is biocompatible, injectable hyaluronic acid (HA) filler (26 mg/ml) PEG cross-
linked with 1% of calcium hydroxyapatite (CaHA) for facial soft-tissue augmentation that provides volume to 
tissues, followed by process of neocollagenesis for improving skin quality.  
AIM: The aim of the present study is to evaluate the biosafety of the product (Lot. 160517-26-1/2 PEG) on human 
keratinocytes cultured in vitro.  
MATERIAL AND METHODS: The experimental model proposed, despite being an in vitro system, allows the 
derivation of useful information to predict the possible activity of the product in further in vivo application. Human 
keratinocytes (HaCaT cells) were treated with the product for 24h at increasing concentrations of product respect 
to control (untreated cells).  
RESULTS: The biosafety of the product to be tested has been evaluated performing different methods: MTT test, 
NRU test, Kenacid Blue assay. Moreover, any possible effect on the structure, morphology, and viability of cells 
has been evaluated. 
CONCLUSION: In conclusion, the results obtained by the different methods show that the product Neauvia 
Stimulate® does not cause any cytotoxic effect and does not affect the correct structure and morphology of cells 
cultures. 
 
 
 
 
 
Introduction 
 
Neauvia Stimulate (MatexLab SA, Lugano, 
CH) is a product which combines pure hyaluronic acid 
of probiotic origin (Bacillus Subtilis) cross-linked with 
PEG (poly-ethylene-glycol) and micromolecules (10-
12 m size) of calcium hydroxyapatite in low 
concentration (1%). The product could be considered 
a "composite" filler (completely biocompatible and 
degradable) with both volumizing effects, typical of the 
HA filler cross-linked polymer [1][2][3], and a 
collagenesis activity. The latter is obtained by the 
action of calcium hydroxyapatite that stimulates the 
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skin self-production of collagen [4][5][6]. 
The aim of the present work is to evaluate the 
in vitro biosafety, in term of cytotoxicity and 
modification of the cellular structure and morphology, 
after treating human keratinocytes cultured in vitro 
with the product Hyaluronic Acid Hydrogel 26 mg/ml 
PEG cross-linked with Calcium Hydroxyapatite 1% 
(Lot. 160517-26-1/2 PEG), named Neauvia Stimulate. 
The experimental model proposed, despite being an 
in vitro system, allows the derivation of useful 
information to predict the possible activity of the 
product in further in vivo applications. 
 
 
Materials and Methods 
 
Sample preparation  
The product Neauvia Stimulate was weighed 
and dissolved at the concentration of 5 mg/ml in 
complete medium constituted by DMEM with 10% 
fetal bovine serum (FBS), one mM L-glutamine and 
antibiotics (100 UI/ml penicillin and 100 μg/ml 
streptomycin). SLS (Sodium Lauryl Sulphate), well-
known cytotoxic substance, was used as positive 
control and was prepared as described for the 
product.  
 
Cell cultures  
Keratinocytes are the most represented cell 
type in the epidermis cells. They grow from the base 
of the epidermis where cells multiply and then migrate 
to the surface of the skin producing lipids, natural 
factors of hydration and keratin. Human immortalised 
keratinocytes used in the assay were a human cell 
line (HaCaT, code BS CL 168). The cell line was 
grown in conditions of complete sterility and 
maintained in incubation at 37°C with 5% carbon 
dioxide (CO2) atmosphere.  
 
Cytotoxicity assay (MTT test)  
The MTT test is a colourimetric cytotoxicity 
assay used to test cell proliferation and viability based 
on mitochondrial efficiency. The MTT, a tetrazolium 
salt that, in case of cells metabolical activity, is 
reduced from the highly reducing mitochondrial 
environment of viable cells by the action of 
mitochondrial dehydrogenase. MTT reduction leads to 
the formation of formazan crystals (Fig. 1) - insoluble 
in the culture medium, but soluble in DMSO - which 
gives the typical purple colour to the mitochondria of 
viable cells. Contrarily, in suffering or dead cells, since 
active mitochondria are lacking, MTT will not be 
reduced resulting in a less intense purple colour [7]. 
For the direct relationship between cellular respiration 
and viability, MTT is considered a good assay to 
identify the non-cytotoxic concentrations of the 
product Neauvia Stimulate.  
 
Figure 1: MTT reduction in formazan. The reaction is catalysed by 
succinate dehydrogenase 
 
For the preparation of the assay, HaCaT cells 
were homogeneously seeded in 96-well plates at a 
density of 1.5 x 10
4
 cells-per-well and incubated at 
37°C with 5% CO2 humidified atmosphere. After 24 h, 
cells were treated (six replicates for each of the eight 
different concentrations) starting with a concentration 
of 5 mg/ml up to the final one of 0.039 mg/ml through 
a serial dilution of 1:2. Cells treated with SLS were 
used as positive control (Ctrl+, starting concentration 
5 mg/ml in complete medium).  
Incubation was performed for 24 h. Following, 
ten μl of MTT stock (5 mg/ml in PBS) were added to 
HaCaT cells at 37°C for two h. The medium was then 
removed, and 100 μl of DMSO was added to the cells. 
Subsequently, absorbance was measured at a 
wavelength of 570 nm using a microplate reader. Cell 
viability was calculated measuring the difference in 
optical density of each of the eight concentrations of 
the tested product concerning control (untreated cells) 
(8). Data were processed using Photox v. 2.0 for IC50 
calculation, which is the concentration of the product 
that determines the 50% of cell viability. 
 
Cytotoxicity assay (NRU test)  
The NRU cytotoxicity assay is a colourimetric 
test based on the ability of viable cells to incorporate 
the dye in lysosomes [9]. Neutral Red (NR, Sigma) is 
a weak cationic dye that readily penetrates cell 
membranes and accumulates intracellularly in 
lysosomes, thereby providing direct information on the 
cell membrane integrity and, indirectly, on the viability 
of cells. For the preparation of the assay, cells were 
seeded and treated as previously described. At the 
end of the treatment, cells were examined under a 
phase-contrast microscope and washed in PBS. One 
hundred µl of the NR medium was then added and 
cells were incubated for three h at 37°C, 5% CO2. 
After the medium has been discarded, an acetic acid 
solution was added to extract the NR from cells, and 
the reading of the absorbance was performed at 540 
nm wavelength using a microplate reader (Tecan 
Sunrise). Cell viability was calculated as previously 
described. 
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Cytotoxicity assay (Kenacid Blue assay)  
The Kenacid Blue test is a colourimetric 
cytotoxicity assay used to test cell viability based on 
the ability of a dye to bind cellular proteins [10]. The 
Kenacid Blue assay system measures total biomass 
by staining proteins (total biomass) with a specially 
developed dye creating a simple, accurate, and highly 
reproducible test. For the preparation of the assay, 
cells were seeded and treated as previously 
described. Cells were then washed with PBS and 
fixed with a 3% glutaraldehyde solution for 20 min at 
room temperature. Fifty µl of the Kenacid Blue Acid 
Stain Solution was added to each well for 20 min at 
room temperature. At the end of the incubation, the 
medium was then discarded, and cells were washed 
with an acetic acid solution (5% in 10% ethanol). 
Finally, 100 µl of Kenacid Blue Assay Extraction 
Solution was added to each well for 20 min at room 
temperature with gentle shaking. Subsequently, the 
absorbance was read at 570 and 690 nm wavelength 
using a microplate reader. Cell survival was calculated 
as previously described. 
 
Evaluation of cell viability 
Cell viability has been evaluated by 
“LIVE/DEAD” (Life Technologies Ltd) commercial kit 
that uses two different fluorescent probes, the red-
fluorescent nucleic acid stain, propidium iodide, and 
the SYTO® nine green-fluorescent nucleic acid stain 
for the determination of live and dead cells. The SYTO 
9 penetrates all cells, those with intact and damaged 
membranes. In contrast, propidium iodide penetrates 
only cells with damaged membranes, causing a 
reduction in the SYTO 9 stain fluorescence when both 
dyes are present. For the preparation of the assay, 
cells were homogeneously seeded onto glass 
coverslips (22 x 22 mm), placed inside Petri dishes 
(35 x 10 mm), at a density of 1 x 10
5
 cells, and 
incubated at 37°C, with 5% CO2 humidified 
atmosphere. After 24 h, cells were treated with two 
concentrations of the product, equal to 2.5 mg/ml and 
1.25 mg/ml, demonstrated to be non-cytotoxic and 
with the best solubility in the culture medium. After 24 
h treatment, an appropriate mixture of the two dyes 
was added to each dish for 15 min. Samples were 
then stored protected from light and analysed using 
fluorescence microscopy.  
 
Evaluation of cell morphology 
The hematoxylin and eosin (EE) staining, 
commonly used in the microscopic study of animal 
tissues and histopathology routine, has been used to 
evaluate any possible effect on cell cultures after the 
treatment with the product Neauvia Stimulate. For the 
preparation of the assay, cells were seeded and 
treated as described in the previous paragraph. At the 
end of the treatment, cells were washed and fixed in 
methanol; subsequently, a 1% hematoxylin-eosin 
solution has been added to each slide. After having 
carefully removed the stain, coverslips has been 
mounted on microscope slides to promote the drying. 
 
Evaluation of cell structure 
 For the study on the effects on the 
cytoskeleton due to the treatment with the product 
Neauvia Stimulate
®
, a fluorescent Phalloidin molecule 
has been used to detect the microfilaments of F-actin 
[11] in immunofluorescence. For the preparation of the 
assay, cells were seeded and treated as previously 
described. After the treatment, HaCaT cells were fixed 
with 4% paraformaldehyde for 20 minutes at room 
temperature and then incubated with the antibody 
Alexa Fluor® 488 phalloidin at room temperature. 
After this period, the excess of phalloidin and any 
residues were removed through two further washes in 
PBS and the nuclei stained with Hoechst 33258. The 
coverslips were then mounted on slides and analysed 
by confocal microscopy. 
 
 
Results  
 
Results are reported in charts, and images 
containing the measurements obtained by cell 
cytotoxicity assays and the evaluation of cell viability, 
structure and morphology after treatment with the 
product Neauvia Stimulate concerning control HaCaT 
cells. Data represented as the mean of at least two 
independent experiments performed in single.  
 
Evaluation of cell cytotoxicity  
HaCaT cells were incubated and treated for 
24 h with eight different concentrations of the product 
Neauvia Stimulate
®
, along with an appropriate positive 
control, to identify a possible cytotoxic effect on cell 
cultures and the concentrations to use in the following 
assay.  
Fig. 2 shows the results of the cytotoxicity 
tests. It is possible to note that, at all concentrations 
tested and in all the three assays, the product 
Neauvia Stimulate did not cause a decrease in cell 
viability so to calculate the IC50 value and, 
consequently, the product did not show cytotoxic 
activity.  
The concentrations of 1.25 mg/ml and 2.5 
mg/ml were chosen for the following assays for their 
best solubility in the culture medium.  
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Figure 2: Graphics of cell viability obtained after 24 h treatment of 
HaCaT cells with the product Neauvia Stimulate®. (A): MTT test; 
(B) NRU test; (C) Kenacid Blue assay 
 
Evaluation of cell viability 
 HaCaT cells were incubated and treated for 
24 h with the concentrations of 1.25 mg/ml and 2.5 
mg/ml of the product Neauvia Stimulate
®
, along with 
an appropriate positive control. Fig. 3 shows the 
representative images obtained with a fluorescence 
microscope of the results of the LIVE/DEAD assay. 
Analysing the images, it is clear that none of the two 
concentrations tested determines a variation in cell 
viability and that the number of stained cells in green 
(live) is comparable to the control (untreated cells). In 
contrast, it is evident an alteration of viability after 
treatment with SLS, with a decrease in the total 
number of observed cells and increased mortality 
(cells stained in red) compared to the control. 
 
Evaluation of cell morphology 
HaCaT cells were incubated and treated for 
24 h with the two previously described concentrations 
of the product Neauvia Stimulate
®
, along with an 
appropriate positive control.  
 
Figure 3: Images obtained using a fluorescence microscope of the 
staining with LIVE/DEAD kit after 24 h treatment with the product 
Neauvia Stimulate®. A) Ctrl (untreated cells); B) SLS (Ctrl+); C) 
product 2.5 mg/ml; D) product 1.25 mg/ml 
 
Fig. 4 shows the representative images in 
optical microscopy of the results of the Hematoxylin-
Eosin test for each tested condition. None of the two 
concentrations of the product does alter the cell 
morphology when compared with the untreated 
control. It is also evident an alteration of the cell 
morphology induced by the SLS, with a remarkable 
decrease in the total number of observed cells and a 
modification of the normal morphology of the HaCaT 
cells compared to the negative control. 
 
Figure 4: Optical microscopy images related to EE staining after 24 
h treatment of HaCaT cells with the product Neauvia Stimulate®. A) 
control (untreated cells); B) SLS (Ctrl +); C) product 2.5 mg/ml; D) 
product 1.25 mg/ml 
 
Evaluation of cell structure 
HaCaT cells were incubated and treated for 
24 h with the two previously described concentrations 
of the product Neauvia Stimulate
®
, along with an 
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appropriate positive control. Fig. 5 shows the 
representative images in confocal microscopy of the 
results obtained by the cytoskeleton’s structure 
evaluation. Analysing the images, it is clear that none 
of the two tested concentrations determines an 
alteration in the structure of cytoskeleton (stained in 
green) compared to the control (untreated cells). In 
contrast, it is evident an alteration of the structure 
after treatment with SLS, with a decrease of the F-
actin labelled and a decrease in the total number of 
observed cells. 
 
Figure 5: Images obtained using a confocal microscope of the 
staining with Phalloidin after 24 h treatment with the product 
Neauvia Stimulate®. A) Ctrl (untreated cells); B) SLS 0.1 mg/ml 
(Ctrl+); C) product 2.5 mg/ml; D) product 1.25 mg/ml 
 
 
Discussion 
 
From the results obtained using in vitro tests, 
we can conclude that the product Neauvia Stimulate
®
 
does not induce any cytotoxicity effect after 24 h 
treatment in human keratinocytes at the tested 
conditions. Moreover, the analyses performed with the 
two concentrations resulted to be with the best 
solubility in cell culture medium, do not cause any 
alteration of cell viability, cell morphology, and 
structure, showing results comparable to control cells, 
which were not treated.  
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